FDA Approvals

Date Posted
Article Title
2/4/2011
Drug Approved to Help Prevent Preterm Birth

Makena for women at risk of delivering early

1/25/2011
1/24/2011
Viibryd Approved for Major Depressive Disorder

When symptoms of depression interfere with daily life

1/18/2011
Natroba Approved for Head Lice

For people 4 years and older

1/10/2011
Abstral Approved for Adults With Cancer Pain

Opioid drug to be distributed via program to deter misuse

12/22/2010
12/21/2010
Device Approved for Dangerous Vessel Bulge

Endurant stent graft treats aneurysm in abdominal aorta

12/17/2010
12/14/2010
Once-Daily Dose Approved for Prezista

Anti-HIV drug sanctioned in combination with ritonavir

11/24/2010
Axiron Approved as First Underarm Testosterone Drug

For men with symptoms of hormone deficiency

11/19/2010
Xgeva Approved to Prevent Fractures in Bone Cancer Patients

Blocks protein that destroys bone cells

11/15/2010
Halaven Approved for Late-Stage Breast Cancer

Injected therapy believed to stifle cancer cell growth

11/15/2010
Vyvanse Approved for Adolescent ADHD

Previously sanctioned for ADHD in adults and children

11/11/2010
Egrifta Approved for HIV-Related Fat Deposits

Lipodystrophy can lead to excess fat near internal organs

11/5/2010
Kombiglyze XR Approved for Adult Type 2 Diabetes

For once-daily blood sugar control

11/5/2010
Cymbalta Approved for Chronic Joint and Muscle Pain

First approved as anti-depressant in 2004

11/4/2010
Ofirmev Sanctioned for Pain and Fever

First U.S.-approved injected form of acetaminophen

11/1/2010
Teflaro Sanctioned for Bacterial Infections

Including pneumonia and methicillin-resistant staph

11/1/2010
Afinitor Approved for Rare Genetic Disorder

Disorder causes non-cancerous brain tumors

10/28/2010
Latuda Approved for Adult Schizophrenia

Symptoms include hallucinations and delusions